Fortrea Holdings Inc. (FTRE) Earnings Call Analysis

NASDAQ · Healthcare · Biotechnology

Earnings Reports

• Fortrea (FTRE) Q2 2026: Book-to-Bill Tops 1.06 as Biotech Pipeline Diversifies
  July 29, 2026
• Fortria (FTRE) Q1 2026: Book-to-Bill Reaches 1.15x as Biotech Pipeline Expands
  May 05, 2026
• Fortria (FTRE) Q4 2025: Book-to-Bill Hits 1.14x as Cost Discipline Unlocks $93M Net Savings
  February 26, 2026
• Fortrea (FTRE) Q3 2025: Book-to-Bill Rises to 1.13x as Biotech Win Rates Double
  November 05, 2025
• Fortria (FTRE) Q2 2025: $150M Cost Cuts Unlock Margin Stability Despite Biotech Win Rate Dip
  August 06, 2025
• Fortria (FTRE) Q1 2025: $150M Cost Reduction Plan Targets Margin Recovery Amid Oncology-Weighted Backlog
  July 06, 2025

Browse all companies